Trials / Completed
CompletedNCT01503944
A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)
Detection of Striatal Dopaminergic Degeneration and Neocortical Amyloid Pathology in Patients With Dementia With Lewy Bodies, Alzheimer's Disease, Parkinson's Disease, and Healthy Elderly Volunteers
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Avid Radiopharmaceuticals · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the ability to identify individuals with dopaminergic degeneration in group of patients with a clinical diagnosis of either dementia with Lewy bodies (DLB) or idiopathic Parkinson's disease and to differentiate them from Alzheimer's disease (AD) and control subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 18F-AV-133 | 185 MBq |
| DRUG | 18F-AV-45 | 185-370 MBq |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2012-01-04
- Last updated
- 2012-08-14
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01503944. Inclusion in this directory is not an endorsement.